COCRYSTAL PHARMA, INC. Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
COCRYSTAL PHARMA, INC. (COCP) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of -$2.50 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2011-11-21
- COCRYSTAL PHARMA, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2011-09-30 was -$2.50M, a 1073.22% decline year-over-year.
- COCRYSTAL PHARMA, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2011-06-30 was -$568.40K, a 1071.61% decline year-over-year.
- COCRYSTAL PHARMA, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2010-09-30 was $256.85K.
- COCRYSTAL PHARMA, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2010-06-30 was $58.50K.
| Period end | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 6 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 9 month |
|---|---|---|---|
| 2011-09-30 | -$2.50M 10-Q · filed 2011-11-21 | -$3.07M derived: sum of 2 quarters · filed 2011-11-21 | -$3.61M 10-Q · filed 2011-11-21 |
| 2011-06-30 | -$568.40K 10-Q/A · filed 2011-09-09 | -$1.11M 10-Q/A · filed 2011-09-09 | |
| 2010-09-30 | $256.85K 10-Q · filed 2011-11-21 | $315.35K derived: sum of 2 quarters · filed 2011-11-21 | $394.92K 10-Q · filed 2011-11-21 |
| 2010-06-30 | $58.50K 10-Q/A · filed 2011-09-09 | $138.07K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |